Oral vaccine platform technology for COVID-19!

iosBio signs exclusive worldwide licensing agreement granting ImmunityBio rights to OraPro™ oral vaccine platform technology for COVID-19.

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *